Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
30
mentions
- X 14
- News 8
- Blogs 4
- YouTube 3
- +1 more

